Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-19

FDA Approved: GABAPENTIN — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

FDA approved a supplemental application for gabapentin from Quallent Pharmaceuticals Health LLC. The approval may modify labeling or indications for the generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)